跳至主要内容
临床试验/IRCT20220213054013N1
IRCT20220213054013N1招募中未知

Evaluation of the effectiveness of IVIg therapy on blood (WBC? lymphocyte count), renal (Cr, urea) and liver parameters (AST, ALT) in COVID-19 patients before and after IVIg therapy.

Esfahan University of Medical Sciences0 个研究点目标入组 196 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
196